Dr. Tillie-Louise Hackett, PhD, ATSF
Dr. Tillie-Louise Hackett, is an Associate Professor and Vice-Chair of Research in the Department of Anesthesiology, Pharmacology & Therapeutics, and Tier I Canada Research Chair in Asthma and COPD Lung Pathobiology & Therapeutics.
Dr. Hackett is an internationally recognized leader in ultra-resolution biomedical imaging modalities and human in vitro models to investigate and treat the pathobiology of asthma and COPD, which daily affects the ability of over 4.5 million Canadians to breathe. Dr. Hackett’s research has been formally recognized by over 35 awards, including the Parker B. Francis Fellowship (2012), Canadian Institutes of Health Research New Investigator Award (2014), and the UBC Faculty of Medicine Distinguished Researcher Award (2018). In 2018, she was named an Inaugural American Thoracic Society Fellow (100 awarded), a mark of distinction and recognition for accomplishments and dedication to the society and field of pulmonary, critical care, and sleep medicine. Dr. Hackett has published over 100 peer-reviewed articles and ranks in the top 0.2% of 157,339 published authors worldwide on obstructive lung diseases (Expertscape.com).
Since 2014, Dr. Hackett has served as the Director of the HLI James C. Hogg Lung Tissue Biobank. Established in 1977, it is one of the largest biobanks in the world, enabling researchers from academia, health authorities, and industry to access comprehensively phenotyped lung samples from over 3,000 patients. Between 2013 – 2018, Dr. Hackett served as the Associate Director of the Centre for Heart Lung Innovation.
Dr. Hackett has served as the primary supervisor for 3 MSc and 8 PhD students, 5 postdoctoral fellows, 4 co-op students, 9 summer students, 3 clinical fellows, and 4 BSc Honours students who have collectively won over 65 fellowships, travel awards, and best presentation awards. Since 2017, she has been recognized annually for Excellence in Student Teaching by the Dean of the Faculty of Sciences.